Wang Yongfang, M.D.

Department:Allergy and Clinical Immunology

Medical School:Zhejiang University School of Medicine, China

Academic Rank:Associate Chief Physician 

Appointment

Clinical / Research Interests

Current research on diagnosis and precision treatment of allergic diseases, including those of the respiratory and skin systems. Previous research focus on cancer stem cells.

Professional Highlights

Zhejiang Provincial Science and Technology Progress Award, First Prize, 2022

Professional Appointments

Committee member for Health Technology Promotion of the China National Health Association

Young member for the Professional Committee of Zhejiang Anti-Cancer Association

Education Experience

M.D., Zhejiang University School of Medicine, 2013-2018

B.D., Zhejiang University School of Medicine, 2008-2013

Research Summary

Dr Wang's current research on the molecular mechanisms of common allergens like dust mites and pets, the pathogenic mechanisms of allergic rhinitis and allergic asthma, related drugs (such as new biotherapeutic drugs), and the exploration of the efficacy markers of desensitization therapy. Previously, she was involved in researches that focus on cancer stem cells.

Publications

Wang Y, Wang H: The emerging role of histone deacetylase 1 in allergic diseases. Frontiers in Immunology 2022, 13:1027403.

Wang Y, Zhou Y, Tao F, Chai S, Xu X, Yang Y, Yang Y, Xu H, Wang K: N-myc downstream regulated gene 1(NDRG1) promotes the stem-like properties of lung cancer cells through stabilized c-Myc. Cancer Letters 2017, 401:53-62.

Current Program

National Natural Science Foundation of China (NSFC)

NO. 81902331, 01/2020-12/2022, 

The role and mechanism of EPCR promoting the stemness characteristics in non-small cell lung cancer stem cells.

Find People

Search by Family Name

Find A Department

Search by Departments